To direct the Secretary of State to develop a strategy to obtain membership status for India in the Asia-Pacific Economic Cooperation (APEC), and for other purposes.

H.R. 4830: To direct the Secretary of State to develop a strategy for Indias membership in the Asia-Pacific Economic Cooperation (APEC), and for other purposes Transatlantic Trade and Investment Partnership (TTIP): Market access, intellectual property, regulatory and other issues including mutual recognition of inspections Trans-Pacific Partnership (TPP): Provisions related to intellectual property, market access and public health issues Other: - Biopharmaceutical innovation policy issues - China intellectual property and market access policy issues - India innovation, intellectual property, and market access policy issues - International market access and intellectual property policy issues - Issues related to PhRMAs Special 301 and National Trade Estimate (NTE) submissions including intellectual property and market access issues - Canada intellectual property and market access policy issues - Colombia intellectual property policy issues - Japan market access and reimbursement policy issues - Turkey market access and reimbursement policy issues - Indonesia intellectual property policy issues - Colombia intellectual property policy issues - UN High-Level Panel on Access to Medicines - Intellectual property and market access policy issues - G7 Summit

Client expense: $1,070,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

H.R. 4830: To direct the Secretary of State to develop a strategy for Indias membership in the Asia-Pacific Economic Cooperation (APEC), and for other purposes Transatlantic Trade and Investment Partnership (TTIP): Market access, intellectual property, regulatory and other issues including mutual recognition of inspections Trans-Pacific Partnership (TPP): Provisions related to intellectual property, market access and public health issues Biopharmaceutical innovation policy issues China intellectual property and market access policy issues India innovation, intellectual property, and market access policy issues International market access and intellectual property policy issues Issues related to PhRMAs Special 301 and National Trade Estimate (NTE) submissions including intellectual property and market access issues Canada intellectual property and market access policy issues Japan market access and reimbursement policy issues Turkey market access and reimbursement policy issues Indonesia intellectual property policy issues Colombia intellectual property policy issues UN High-Level Panel on Access to Medicines - Intellectual property and market access policy issues G7 Summit

Client expense: $5,820,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)